BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34348001)

  • 1. NK Cell Development and Function in Patients with Fanconi Anemia.
    Hashemi E; Bjorgaard S; Wang D; Uyemura B; Riese M; Thakar MS; Malarkannan S
    Crit Rev Immunol; 2021; 41(2):35-44. PubMed ID: 34348001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
    Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
    Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia.
    Chang L; Zhang L; Zhao B; Cheng X; Wan Y; Zhang R; Yuan W; Gao X; Zhu X
    BMC Med Genomics; 2023 Nov; 16(1):290. PubMed ID: 37974167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel target genes involved in Indian Fanconi anemia patients using microarray.
    Shyamsunder P; Ganesh KS; Vidyasekar P; Mohan S; Verma RS
    Gene; 2013 Dec; 531(2):444-50. PubMed ID: 24036430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
    Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia.
    Soulier J
    Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
    Savage SA; Walsh MF
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):657-668. PubMed ID: 30047418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.
    Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C
    Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.
    Shabrish S; Kelkar M; Chavan N; Desai M; Bargir U; Gupta M; Mehta P; Chichra A; S C; Taur P; Saxena V; Vundinti BR; Madkaikar M
    Front Immunol; 2019; 10():490. PubMed ID: 30949167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fanconi anemia--genotoxic stress and senescence of hematopoietic stem cells].
    Yamashita T; Oda T; Sekimoto T
    Nihon Rinsho; 2008 Mar; 66(3):477-82. PubMed ID: 18330024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
    Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
    Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anaemia and cancer: an intricate relationship.
    Nalepa G; Clapp DW
    Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holding All the Cards-How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability.
    Datta A; Brosh RM
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30813363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.